WI

Healthcare · Pharmaceuticals

Windlas Biotech Ltd (WINDLAS)

₹961.25

Mkt cap
₹2,017 Cr
P/E ratio
30.20
P/B
3.48
Div yield
0.64%
ROE
12.20%
ROCE
15.90%
EPS (TTM)
₹31.83
Book value
₹276
52W range
697–1,182
Sector
Healthcare

Price history

Previous close

Windlas Biotech Ltd is a leading domestic pharmaceutical formulations contract development and manufacturing organization (CDMO). The company manufactures both solid and liquid pharmaceutical dosage forms and provides a comprehensive range of CDMO services ranging from product discovery, product development, and commercial manufacturing of generic products, including complex generics. [1]

NSE WINDLASBSE 543329
Health check
Mixed
ValuationFair
ProfitabilityAverage
GrowthModerate
TechnicalsNeutral
52-week range
−18.67% from high
₹961
₹697+37.83% from low₹1,182
Current
₹961.25
Prev close
₹982.45
Day
−2.16%
Price performance
1D
−2.18%
1W
−4.04%
1M
+6.73%
3M
−2.75%
6M
+22.84%
1Y
+17.10%
YTD
+21.85%

Financials

Revenue, profit & margin
P/E ratio
30.2×
WINDLAS is 10% below the sector median of 33.4×
WINDLAS30.2×
Sector median33.4×
 Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026Trend
Sales153162171175187195203210222233238248264
YoY Sales growth+15%+36%+22%+21%+22%+20%+18%+20%+19%+20%+18%+18%+19%
Expenses134142149154164170177184194209213221235
Operating Profit19202221232526272924252729
OPM %12%13%13%12%12%13%13%13%13%10%11%11%11%
Other Income3344545545454
Interest0000111111122
Depreciation3346678788878
Profit before tax18202318202021232420202323
Tax %23%24%25%26%23%24%22%24%25%25%21%23%23%
Net Profit14151713161516181815161818
EPS in Rs6.757.268.156.457.497.297.778.438.457.097.598.558.75
Raw PDF

Earnings

Results dates & reactions
No upcoming results date on calendar.

Fresh quarters land in the Financials table above, tagged NSE until screener catches up.

Avg earnings-day move +10.13% · closed higher next day 2 of last 2
 Q1FY27Q2FY27
Broadcast10 Aug '26◦5 Nov '26◦
Earnings day+12.32%+7.94%
+1 day+6.56%+5.75%
+5 days+9.33%+6.07%
+15 days+20.09%—
+30 days+28.32%—
FilingXBRLXBRL

Corporate actions

Last 6 months

No recent corporate actions

Dividends, splits, and bonuses in the last six months show up here.

Shareholding

as of Sep 2026
63.31%Promoter
Promoters63.31%
FIIs2.09%0.05
DIIs7.24%2.60
Public27.35%2.55
Ownership trend

Peers

8 companies
Valuation vs quality
P/E × ROCE · bubble = market cap
NameCMPP/EMkt CapDiv YldNP QtrQtr Profit VarSales QtrQtr Sales VarROCE
Sun Pharma.Inds.₹1,867.5036.424,48,0760.86%1,995−10.53%16,199+11.88%20.53%
Divi's Lab.₹11,080.0086.072,94,1390.27%1,127+63.57%3,676+35.40%21.97%
Torrent Pharma.₹4,691.2082.191,78,4380.81%534−10.03%4,979+50.79%15.19%
Laurus Labs₹2,220.0089.521,19,9490.09%436+126.43%2,206+33.44%17.76%
Zydus Lifesci.₹1,192.0026.241,18,9020.08%928−27.96%7,910+29.17%21.14%
Dr Reddy's Labs₹1,377.9041.111,15,0920.58%913−31.35%8,698−1.48%13.04%
Cipla₹1,394.5036.281,12,6600.93%852−35.05%7,404−2.44%15.49%
Windlas Biotech₹977.2030.252,0170.64%18+1.40%264+18.66%15.90%
Median: 160 Co.₹449.5033.402,0180.08%13+33.73%179+21.23%14.94%

Filings